These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13720632)

  • 1. [Brief report on the potential area of kala-azar in Guatemala and results of its epidemiologic study].
    DE LEON JR
    Rev Col Med Guatem; 1960 Dec; 11():243-4. PubMed ID: 13720632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discovery of the first endemic zone of kala-azar in Guatemala and its epidemiological conditions].
    DE LEON JR; FIGUEROA LN
    Rev Col Med Guatem; 1959 Dec; 10():240-5. PubMed ID: 13849528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Final survey for the preliminary evaluation of kala-azar in Guatemala].
    DE LEON JR
    Rev Col Med Guatem; 1961 Sep; 12():158-60. PubMed ID: 13884314
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An estimate of kala azar in 1991 in district Vaishali and Bihar.
    Bora D; Singh J; Bhattacharjee J; Kureel VR; Singh S; Sharma RS
    J Commun Dis; 1994 Jun; 26(2):120-2. PubMed ID: 7989675
    [No Abstract]   [Full Text] [Related]  

  • 7. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral leishmaniasis (kala-azar) in Germany].
    Meissner W; Seybold G
    Med Welt; 1966 Jan; 1():48-52. PubMed ID: 5942364
    [No Abstract]   [Full Text] [Related]  

  • 9. Present situation of vector-control management in Bangladesh: a wake up call.
    Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
    Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kala azar and cutaneous leishmaniasis in Yugoslavia].
    TODOROVIC K
    Zentralbl Bakteriol Orig; 1957 Jan; 167(5):390-5. PubMed ID: 13423624
    [No Abstract]   [Full Text] [Related]  

  • 11. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
    Ramesh V; Singh R; Salotra P
    Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A seroepidemiological study of kala-azar in Nepal. A preliminary report.
    Joshi DD; Srivastava L; Sehgal S
    J Commun Dis; 1985 Sep; 17(3):248. PubMed ID: 3835187
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of visceral leishmaniasis in the Tharaka District, Kenya.
    Pelizzi M; Verna M; Vanelli M
    Acta Biomed; 2006 Aug; 77(2):103-5. PubMed ID: 17172190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).
    Kumar V; Kesari S; Dinesh DS; Tiwari AK; Kumar AJ; Kumar R; Singh VP; Das P
    J Vector Borne Dis; 2009 Sep; 46(3):225-9. PubMed ID: 19724087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kala-azar in Mexico; and ecological problem from study].
    Biagi F; López R; De Biagi AM
    Rev Inst Salubr Enferm Trop; 1965; 25(1):3-12. PubMed ID: 5890760
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autochthonous kala-azar in Minas Gerais].
    MARTINS AV; BRENER Z; MOURAO OG; LIMA MM; DE SOUZA MA; DA SILVA JE
    Rev Bras Malariol Doencas Trop; 1956 Oct; 8(4):555-63. PubMed ID: 13494875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.